Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2008-01-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Effect of Caffeine Consumption on Speech Understanding in Noise in Young Adults
NCT06942117
Effects of CI on Tinnitus and Its Symptoms
NCT05453019
Correlation Analysis of Hearing Thresholds, Validated Questionnaires and Psychoacoustic Measurements in Tinnitus Patients
NCT00976547
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
NCT04192773
Internet-based Guided Self-help for Chronic Tinnitus
NCT01205919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
caffeine
caffeine daily intake will be reduced form 150 ml per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* THI \> 38
* no central acting drugs in the last 6 months
* tympanogram type A-n
* daily intake of caffeine greater than 150 ml
Exclusion Criteria
* concomitant TMJ disorders
* abnormal otoscopy
* mixed and conductive hearing losses
* Ménière disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculdade de Medicina de Valenca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Valencia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ricardo R Figueiredo, MD,MSc
Role: STUDY_CHAIR
Faculdade de Medicina de Valença
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculdade de Medicina de Valença
Valença, Rio de Janeiro, Brazil
OTOSUL Otorrinolaringologia Sul-Fluminense
Volta Redonda, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMV 001 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.